ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664266 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664266; 2) Community: the network communities that were significantly associated with the response to NSC 664266; 3) Molecule: the relationships between components within communities and NSC 664266; 4) MDR: the compounds that were significantly associated with the NSC 664266.

NSC Compound Enrichment Correlation
NSC 717468 Null 0.00485717408280859 0.30920024
NSC 718781 Erlotinib hydrochloride 0.00485717408280859 -0.39902304
NSC 726217 Combretastatin A4-analogue 0.00485717408280859 0.31088407
NSC 726578 Null 0.00485717408280859 0.1454167
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.00485717408280859 0.30457694
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.00485717408280859 0.36728194
NSC 750050 Null 0.00485717408280859 0.4536312
NSC 151982 Null 0.00485717408280862 0.34713619
NSC 266046 Oxaliplatin 0.00485717408280862 0.52651153
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.00485717408280862 0.42772687
Total:170  Current:41    [First] [Prev] [Next] [Last]